Inventor

Jonathan L. Sessler

Inventor
Austin, TX, US

Overview

78→
Patents
1990–2019
Patent span
Human necessities
Primary field (CPC A)

Patents· 78 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
C07DHeterocyclic compounds21%
C07HSugars15%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations12%
A61LMethods or apparatus for sterilising materials or objects in general9%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry7%
C12NMicroorganisms or enzymes5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
Y10TTechnical subjects covered by former us classification1%
C07KPeptides1%
PatentTitleYear
10,406,167Texaphyrin-Pt(IV) conjugates and compositions for use in overcoming platinum resistance201910,329,326Melanocortin 1 receptor ligands and methods of use20199,585,910'Polymers functionalized with ion-specific recognition elements'20179,441,013'Melanocortin 1 receptor ligands and methods of use'20168,802,074'Polymers functionalized with ion-specific recognition elements'20148,580,845'Functionalized expanded porphyrins'20138,507,531'Water-soluble zinc ionophores, zinc chelators, and/or zinc complexes and use for treating cancer'20137,838,536'Water-soluble zinc ionophores, zinc chelators, and/or zinc complexes and use for treating cancer'20107,579,338'Methods and compositions for treating atheroma, tumors and other neoplastic tissues'20097,547,689'Methods and compositions for treating atheroma, tumors and other neoplastic tissues'20097,528,125'Water-soluble zinc ionophores, zinc chelators, and/or zinc complexes and use for treating cancer'20097,109,188'Methods and compositions for treating atheroma, tumors and other neoplastic tissue'20067,041,819'Halogenated calixpyrroles and uses thereof'20066,984,734'Cyclo[n]pyrroles and methods thereto'20066,825,186'Method and compositions for treating atheroma, tumors and other neoplastic tissue'20046,657,058'Metal free texaphyrin synthesis'20036,608,196'Process for solid supported synthesis of pyruvate-derived compounds'20036,482,949'Colormetric sensor compositions and methods'20026,375,930'Membrane incorporation of texaphyrins'20026,207,660'Texaphyrin conjugates and uses thereof'20016,072,038'Conjugates of texaphyrins'20006,069,140'Pharmaceutical compositions comprising texaphyrins'20005,994,535'Water soluble texaphyrin metal complex preparation'19995,969,111'Texaphyrins substituted with imidazole are provided'19995,955,586'Highly boronated derivatives of texaphyrins'19995,888,997'Radiation sensitization using texaphyrins'19995,837,866'Phosphoramidite derivatives of macrocycles'19985,808,059'Matrix-supported sapphyrins'19985,801,229'Metal complexes of texaphyrins'19985,798,491'Multi-mechanistic chemical cleavage using certain metal complexes'19985,763,172'Method of phosphate ester hydrolysis'19985,756,726'Methods of producing singlet oxygen using compounds having improved functionalization'19985,744,302'Method for separating molecules'19985,733,903'Treatment of neoplastic tissue by water-soluble texaphyrine metal complexes'19985,714,328'RNA photocleavage using texaphyrins'19985,672,490'Method of cleaving DNA'19975,632,970'Fluoresence detection using texaphyrins'19975,633,354'Phosphoramidite derivatives of texaphyrins'19975,622,946'Radiation sensitization using texaphyrins'19975,622,945'Rubyrin macrocycles'19975,607,924'DNA photocleavage using texaphyrins'19975,601,802'Methods of MRI enhancement using compounds having improved functionalization'19975,599,923'Texaphyrin metal complexes having improved functionalization'19975,599,928'Texaphyrin compounds having improved functionalization'19975,595,726'Chromophore probe for detection of nucleic acid'19975,594,136'Texaphyrin solid supports and devices'19975,591,422'Texaphyrin complexes having improved functionalization'19975,587,463'Texaphyrin macrocycles and metal complexes thereof'19965,587,478'Sapphyrin multimers'19965,587,371'Texaphyrin-oligonucleotide conjugates'19965,583,220'Pyrole nitrogen-substituted texaphyrins'19965,580,543'Method of magnetic resonance image enhancement'19965,569,759'Water soluble texaphyrin metal complex preparation'19965,567,687'Texaphyrins and uses thereof'19965,565,552'Method of expanded porphyrin-oligonucleotide conjugate synthesis'19965,559,207'Texaphyrin metal complex mediated ester hydrolysis'19965,543,514'Water-soluble sapphyrins'19965,530,123'Sapphyrin chelator derivatives'19965,525,325'Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles'19965,504,205'Reduced sp.sup.3 texaphyrins'19965,475,104'Water soluble texaphyrin metal complexes for enhancing relaxivity'19955,457,183'Hydroxylated texaphyrins'19955,457,195'Sapphyrin derivatives and conjugates'19955,451,576'Tumor imaging and treatment by water soluble texaphyrin metal complexes'19955,439,570'Water soluble texaphyrin metal complexes for singlet oxygen production'19955,432,171'Water soluble texaphyrin metal complexes for viral deactivation'19955,410,045'Rubyrin and related expanded porphyrins'19955,369,101'Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles'19945,302,714'Sapphyrins, derivatives and syntheses'19945,292,414'Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles for singlet oxygen production'19945,272,142'Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles and methods for treating tumors'19935,256,399'Aromatic pentadentate expanded porphyrins in magnetic resonance imaging'19935,252,720'Metal complexes of water soluble texaphyrins'19935,162,509'Process for preparing expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles'19925,159,065'Sapphyrins, derivatives and syntheses'19925,120,411'Photodynamic activity of sapphyrins'19925,041,078'Photodynamic viral deactivation with sapphyrins'19914,935,498'Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles'1990

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1990–2019Patents assigned to UNIV TEXAS (65)· patent assignee history
1990–2019Based in Austin, TX, US· patent location history
1996–2009Patents assigned to PHARMACYCLICS INC (28)· patent assignee history
2001–2009Based in Sunnyvale, CA, US· patent location history
2009–2016Patents assigned to SESSLER JONATHAN L (6)· patent assignee history
2009–2013Patents assigned to MAGDA DARREN (3)· patent assignee history
2016–2019Patents assigned to BOARD OF REGENTS UNIV OF TEXAS SYSTEM (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV TEXAS651990–2019
PHARMACYCLICS INC281996–2009
SESSLER JONATHAN Lself62009–2016
MAGDA DARREN32009–2013
BOARD OF REGENTS UNIV OF TEXAS SYSTEM22016–2019
Locations
LocationPatentsSpan
Austin, Texas, US761990–2019
Sunnyvale, California, US22001–2009